Frequently Asked Questions
The market is segmented based on , By Indication (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries, Others), Product Type (Oral, Parenteral, Implants, Gel/Creams, Patches, Buccal Adhesive, Others), Drug Active Ingredient (Testosterone Cypionate, Testosterone, Testosterone Enanthate, Methyltestosterone, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Testosterone Replacement Therapy Market size was valued at USD 1893.13 USD Million in 2022.
The Global Testosterone Replacement Therapy Market is projected to grow at a CAGR of 4.6% during the forecast period of 2023 to 2030.
The major players operating in the market include AbbVie , Bausch Health Companies , Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Cipla , Lupin, Sun Pharmaceuticals Industries Ltd, Hikma Pharmaceuticals PLC, Braeburn , Johnsons & Johnsons Services , Boehringer Ingelheim International GmbH, Allergan, Sun Pharmaceutical Industries Ltd, Sanofi, AstraZeneca, GlaxoSmithKline Plc, Novartis AG, Pfizer , Amneal Pharmaceuticals LLC, Alvogen.
The market report covers data from the U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina and Rest of South America.
